Entering text into the input field will update the search result below

Glaxo, Sanofi near £500M COVID-19 vaccine deal with the U.K.

Jul. 05, 2020 4:06 AM ETSanofi (SNY), GSKGSK, SNYBy: Yoel Minkoff, SA News Editor18 Comments
  • Sanofi (NASDAQ:SNY) and GlaxoSmithKline (NYSE:GSK) are close to a £500M deal to supply the British government with 60M doses of their coronavirus vaccine, according to the Sunday Times.
  • The business department is understood to be taking an option to buy the vaccine from the pharma giants should it work in human trials, which are due to begin in September.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.